Non-Executive Director
Dr. Marthak comes with rich experience in Clinical Research of nearly 40 years. Dr. Marthak has conducted many Phase 1 studies including First in Human studies, and complex clinical trials.
He has held senior positions in several Indian and Global pharmaceutical companies such as Ciba – Geigy (Novartis), GSK, Pfizer, and Ranbaxy, and in leading CROs and has experience in conducting clinical trials across several geographies including USA, UK, Europe, China, Japan, and South Africa.
Dr. Marthak’s last assignment was as a Member of the Board of Directors at Lambda Therapeutic Research Ltd. Dr. Marthak was a Board member during our formative years.
Dr. Marthak is highly respected amongst regulatory authorities for his knowledge of international clinical research guidelines.
He is one of the accredited members for GCP training by CDSA, India and contributed to the New Clinical Trial Rules implemented in March 2019.
Dr. Marthak is also the Co-Chairman of the Medical Committee of IDMA and a member of the Pharmaceutical and Biotech Committees of the Confederation of Indian Industries.
He is a renowned speaker at International and National Conferences, besides being actively involved in academics.
Dr. Marthak is a qualified M.D. in Internal Medicine from Grant Medical College, a Fellow of the American College of Clinical Pharmacology, a Fellow of the Royal Society of Medicine, U.K., and a Fellow of the Faculty of Pharmacology, University of London.